Skip to content

Quantitative proteomic analysis and bioinformatics research of proteins in retinoblastoma

Quantitative proteomic analysis and bioinformatics study of proteins in retinoblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026673
Enrollment
Unknown
Registered
2019-10-17
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinoblastoma

Interventions

Tumor Initial diagnosis group:Protein extracted from urine
Normal controls:Protein extracted from urine
Non-tumor group of ophthalmic diseases:Protein extracted from urine
Tumor cure group:Protein extracted from urine

Sponsors

Beijing Children's Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for children with RB: (1) Chinese Han children aged 0-18; (2) Children treated and/or operated on at Beijing Children's Hospital,2019/11/1-2020/10/31; (3) RB was diagnosed by more than two experienced senior specialists on the basis of medical history, physical examination, orbital MR and fundus examination. 2. Inclusion criteria for normal controls: (1) Normal Chinese Han children aged 0-18 years, sex, age ratio matched with the patient group, all samples from healthy children, regular imaging and biochemical testing no obvious organic or psychiatric lesions; (2) All data were assessed as non-RB by the blind method of two senior specialists; 3. Inclusion criteria for the non-RB group of ophthalmic diseases: (1)2019/11/1-2020/10/31 Retinal diseases (retinal artery and vein occlusion, perivenous retinal inflammation, Coats'disease, diabetic and hypertensive retinopathy and central serous chorioretinopathy, macular cystoid edema, macular anterior retinal membrane, retinitis pigmentosa), optic nerve diseases (optic disc dysplasia, optic glioma, optic nerve meningioma, optic nerve atrophy) and non-refractive diseases such as non-RB.

Exclusion criteria

Exclusion criteria: (1) with other systemic diseases; (2) with a recent history of infection; (3) the family history of other diseases was excluded; (4) Without history of other diseases in the eye and no drugs were taken at present.

Design outcomes

Primary

MeasureTime frame
Protein expression;

Countries

China

Contacts

Public ContactNi Xin

Beijing Children's Hospital, Capital Medical University

bchebh@163.com+86 18801289275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026